Company intelligence / Profile preview

Brain Navi Biotechnology

Zhubei City, Hsinchu County, Taiwanbrainnavi.com ↗

Ownership: Private
Development stage: Commercial

Overview

NaoTrac has completed clinical trials in Taiwan and is now approved for commercial use in Europe, Taiwan, and the United States. The device has demonstrated high precision and efficiency for a range of neurosurgical procedures.

Therapeutic areas: Neurology
Modalities: DeviceRobotic-assisted surgeryArtificial intelligence-based navigation system
Industry: Surgical Medical Devices

Drug pipeline

2 assets

NaoTrac

Commercial

Indications: Neurosurgery, Brain tumor biopsy, Intracranial hemorrhage

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborated with TSMC Charity Foundation to deploy Zero-contact Medical Stations across hospitals in TaiwanMOU with Hualien Tzu-Chi Medical Center to establish a training center for robotic neurosurgery

Beyond the preview

Go deeper on Brain Navi Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain Navi Biotechnology.

Explore the full profile